BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AssayMetrics and Cambridge Research Biochemicals Collaborate in the Field of Fluorescence Lifetime Technology


9/4/2012 11:02:01 AM

Cardiff and Cleveland, UK, 3rd September 2012: UK company AssayMetrics Ltd, a Discovery Tools company, is pleased to announce collaboration with Cambridge Research Biochemicals Ltd, the UK’s most established peptide and antibody company.

Fluorescence Lifetime is a new and ground-breaking assay technology used in the biochemical screening of new drugs in High Throughput Screening and compound characterisation roles in the pharmaceutical industry.

The collaboration involves Cambridge Research Biochemicals making key peptide substrates labelled with AssayMetrics’ Fluorescence Lifetime dyes. The peptides are used to screen novel drugs in equipment such as AssayMetrics’ Fluospec® FL reader and are employed in assays involving kinases, proteases, protein:protein interactions and other target enzyme systems.

The collaboration brings together two companies leading their respective fields to be able to offer solutions to the pharmaceutical industry enabling faster, more efficient and cheaper drug discovery and development, thereby improving the effectiveness of pharmaceutical R&D.

Dr Pierre Graves, MD of AssayMetrics Ltd commented, “This is exciting news as Cambridge Research Biochemicals have considerable expertise in making the type of complex peptides needed for innovative discovery.” Emily Humphrys, Commercial Director of Cambridge Research Biochemicals was equally positive: “This technology has so much potential that we are really pleased to be collaborating with AssayMetrics at this early stage.” (ENDS)

AssayMetrics Ltd is a Discovery Tools company with more than 70 years experience providing novel fluorescence technologies, dye labelling reagents, enzyme substrates, imaging agents and instruments for use in drug discovery and related applications. Further information on the Fluospec® FL reader, PURETIME® reagents or other services can be obtained by contacting Dr Pierre Graves, Managing Director.

AssayMetrics Ltd

Cardiff Medicentre, Heath Park

Cardiff

CF14 4UJ

Tel: +44 (0)29 2002 6269

Fax: +44 (0)29 2075 0239

e-mail:pierre.graves@assaymetrics.com

http://www.assaymetrics.com

Cambridge Research Biochemicals has over 30 years’ experience of providing custom-made research tools for the International Life Science Community. The company is the world’s second oldest peptide manufacturer specialising in the design and synthesis of peptides together with the custom production of polyclonal and monoclonal antibodies. For further information contact Emily Humphrys, Commercial Director.

Cambridge Research Biochemicals

10 Belasis Court

Belasis Hall Technology Park

Billingham

Cleveland

TS23 4AZ

Tel: +44 (0)1642 567180

Fax: +44 (0)1642 567181

e-mail: crbsales@crbdiscovery.com

http://www.crbdiscovery.com



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->